Literature DB >> 21189203

Continuous infusion versus single bolus popliteal block following major ankle and hindfoot surgery: a prospective, randomized trial.

Robin Elliot1, Christopher J Pearce, Chris Seifert, James Df Calder.   

Abstract

BACKGROUND: Popliteal sciatic nerve blockade is a commonly used technique employed in the management of postoperative pain following foot and ankle surgery. Recent studies have shown that for outpatient surgery, for moderately painful procedures, a continuous infusion of local anesthesia via an in-dwelling catheter for 48 to 72 hours leads to reduced opiate analgesic requirements and improved pain and patient satisfaction scores.
MATERIALS AND METHODS: A prospective, randomized, double blind, placebo-controlled trial of a continuous infusion of bupivacaine verses normal saline via a popliteal catheter after a single bolus popliteal block for 72 hours after major ankle and hind foot surgery was performed in 54 patients.
RESULTS: The average pain scores overall were low (range, 1.1 to 3.6 on a Visual Analogue Scale of 0 to 10) throughout the study period. Statistically significantly lower pain scores with significantly less requirement for supplementary opiate analgesic agents were seen in the treatment group.
CONCLUSION: Despite the statistically significant findings, with such low pain scores in both groups, we believe it remains debatable whether the extra time and cost involved warrants the use of a continuous popliteal blockade over a single bolus injection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21189203     DOI: 10.3113/FAI.2010.1043

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  8 in total

1.  The effect of regional anesthesia blocks on post-operative pain after ambulatory orthopedic trauma surgery.

Authors:  Diana G Douleh; Lori Chambers; Joshua A Parry
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-08-21

2.  Impact of self-coiling catheters for continuous popliteal sciatic block on postoperative pain level and dislocation rate: a randomized controlled trial.

Authors:  Rosa Nickl; Oliver Vicent; Thomas Müller; Anne Osmers; Konrad Schubert; Thea Koch; Torsten Richter
Journal:  BMC Anesthesiol       Date:  2022-05-24       Impact factor: 2.376

Review 3.  Perioperative pain management and chronic postsurgical pain after elective foot and ankle surgery: a scoping review.

Authors:  Cierra Stiegelmar; Yibo Li; Lauren A Beaupre; M Elizabeth Pedersen; Derek Dillane; Martha Funabashi
Journal:  Can J Anaesth       Date:  2019-04-24       Impact factor: 5.063

4.  Comparable Postoperative Pain Levels Using 2 Different Nerve Blocks in the Operative Treatment of Displaced Intra-articular Calcaneal Fractures.

Authors:  Siem A Dingemans; Kristian J de Ruiter; Merel F N Birnie; J Carel Goslings; Gan van Samkar; Tim Schepers
Journal:  Foot Ankle Int       Date:  2017-09-16       Impact factor: 2.827

5.  AnAnkle Trial study protocol: a randomised trial comparing pain profiles after peripheral nerve block or spinal anaesthesia for ankle fracture surgery.

Authors:  Rune Sort; Stig Brorson; Ismail Gögenur; Ann Merete Møller
Journal:  BMJ Open       Date:  2017-06-02       Impact factor: 2.692

6.  The efficacy and safety of continuous versus single-injection popliteal sciatic nerve block in outpatient foot and ankle surgery: a systematic review and meta-analysis.

Authors:  Hsuan-Hsiao Ma; Te-Feng Arthur Chou; Shang-Wen Tsai; Cheng-Fong Chen; Po-Kuei Wu; Wei-Ming Chen
Journal:  BMC Musculoskelet Disord       Date:  2019-10-10       Impact factor: 2.362

7.  Popliteal sciatic nerve block versus spinal anesthesia in hallux valgus surgery.

Authors:  Hyun-Jun Jeon; Young-Chul Park; Jong Nam Lee; Jun-Seok Bae
Journal:  Korean J Anesthesiol       Date:  2013-04-22

8.  Patient satisfaction and gender composition of physicians - a cross-sectional study of community health services in Hubei, China.

Authors:  Change Xiong; Xiao Chen; Xinyuan Zhao; Chaojie Liu
Journal:  BMC Health Serv Res       Date:  2018-03-27       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.